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Abstract 
 
Unquestionably, the last six decades of research on various animal models have advanced 
our understanding of the mechanisms that underlie the many complex characteristics of 
amblyopia as well as provided promising new avenues for treatment. While animal models in 
general have served an important purpose, there nonetheless remain questions regarding the 
efficacy of particular models considering differences across animal species, especially when 
the goal is to provide the foundations for human interventions. Our discussion of these 
issues culminated in three recommendations for future research to provide cohesion across 
animals models as well as a fourth recommendation for acceptance of a protocol for the 
minimum number of steps necessary for translation of results obtained on particular animal 
models to human clinical trials. The three recommendations for future research arose from 
discussions of various issues including the specific results obtained from use of different 
animal models, the degree of similarity to the human visual system, the ability to generate 
animal models of the different types of human amblyopia as well as the difficulty of scaling 
developmental timelines between different species. 
 
Introduction 
In considering animal models of all human diseases, including developmental disorders such 
as amblyopia, there is a concern as to whether experiential or other manipulations imposed 
in early postnatal life on animals having a normal genetic background can adequately mimic 
the human situation where there is a possible genetic contribution to the experiential 
abnormality. For example, in human amblyopia there is a potential genetic contribution to 
anisometropia, strabismus and media opacities that are the experiential abnormalities 
associated with the common subtypes of amblyopia and their presumed cause. Although 
research performed with animal models cannot at present mimic a possible genetic 
susceptibility for these amblyogenic factors in certain patients with amblyopia, researchers 
are aware that experiential manipulations of the early visual input alone in animal models 
may not precipitate the entire set of molecular, anatomical and physiological events that 
occur in all human patients with amblyopia.  
 
The four specific recommendations we make emerged from a wide-ranging discussion of the 
value of the various commonly employed animal models for amblyopia from rodents to 
non-human primates (NHP). The obvious advantages of NHP (such as monkeys) that 
possess similarly organized visual pathways and vision to humans (such as a fovea, smooth 
pursuit eye movements, excellent spatial vision including stereoscopic vision, semi-
decussated visual pathways and multiple visual cortical areas) are offset by many 
considerations that have motivated the choice of alternative models. Among the barriers to 
widespread use of NHP have been their long gestation time, small litter size, and the 
protracted length of key critical periods in visual system development. Added to these 
barriers are the attendant regulatory requirements and costs associated with establishment 
and maintenance of a primate breeding colony required to produce infant animals of known 
ages. Discussion of the value of various animal models and models of strabismic amblyopia 
in particular, prompted debate among participants on the importance of a fovea or a region 
of central retinal specialization with respect to the ability of detection of strabismus or 
eccentric fixation. In passing it was noted that although carnivores such as cats do not 
possess a rod-free fovea they do have a central region of retinal specialization with a high 
cone density, the area centralis. The decline in resolution with eccentricity in cats has been 
documented by both behavioral techniques (Berkeley, Kitterle and Watkins, 1975; Pasternak 
and Horn, 1991) and from electrophysiological recordings of the spatial resolution of retinal 
ganglion cells (Clelan, Harding and Tulunay-Keesey, 1979). Both measurements reveal a 
regular decline from a central peak but with a more gradual slope than observed in humans. 
The four recommendations are discussed below in turn.  
 
Recommendation 1. Documentation of the Perceptual Performance Space of Present 
and Putative Animal Models 
 
  
Consensus on the behavioral and perceptual repertoire of each species will identify the most 
appropriate features of amblyopia to address with particular animal models. Furthermore, 
discovery of similarities in experimental results regarding the performance spaces of two or 
more species would promote efforts to establish the extent of consensus across results from 
use of these species as models of various forms of amblyopia.  
 
Because of the complexity and diversity of amblyopia in humans, as well as species 
differences in the organization of the retina and central visual pathways, it is not surprising 
that certain animal models do not allow a perfect recapitulation of the clinical 
symptomology. Primate models exhibit remarkably similar behavioral deficits to those 
observed in the various forms of human amblyopia so that their cortical correlates are of 
particular interest for an understanding of their underlying cause. By contrast, the ability to 
replicate certain forms of amblyopia such as strabismic or anisometropic amblyopia is 
limited or impossible in other species. Cats and particularly rodents show a declining 
similarity to humans in their manifestation of deprivation amblyopia. Deprivation amblyopia 
is the only form of amblyopia that can be modeled in all species, but the reduction in acuity 
upon monocular deprivation is dramatically different across species. While rodent models 
exhibit a single octave reduction in grating acuity, macaques remain effectively blind in the 
deprived eye after this manipulation (Harwerth, Smith, Boltz et al., 1983). Kittens also appear 
blind immediately after monocular deprivation (MD) but show some recovery afterward 
(Giffin and Mitchell, 1978; Mitchell, 1988). Participants discussed, but without reaching 
consensus, whether the discordant magnitude of the effects of MD reflected fundamental 
anatomical or physiological dissimilarities in the organization of visual pathways across 
species, or else arose from species differences in the plasticity of neural circuitry.  
 
As an offset to considerations based solely on the inability for adequate modeling of all 
forms of amblyopia and their poor vision, rodents by far possess the highest throughput and 
flexibility of experimentation, which has allowed visual circuits to be probed down to the 
cellular and molecular level in ways that are unfeasible for other species and particularly 
NHP models. The power of these two contrasting arguments with respect to the use of 
rodents versus NHP suggests that it would be imprudent to discard any given species on the 
basis of an individual shortcoming but to use each animal model based on its strengths.  
 
Discussion of the value of various animal models revealed substantial gaps in our knowledge 
of the perceptual performance of many species and especially rodents. The lack of 
knowledge of specific visual thresholds became evident in discussion of the role of particular 
anatomical or physiological features or the magnitude of the perceptual deficits on different 
measures of spatial resolution such as grating acuity, Snellen acuity and the various 
hyperacuities. Another example arose on contemplation of the role of binocular cells in the 
visual cortex of rats and mice. Although the recent observation (Schol, Burge and Priebe, 
2013) that cells in the binocular zone of the visual cortex of mice were tuned to retinal 
disparity, albeit in a crude fashion with respect to that observed in the cat, discussion of their 
possible functional role was hampered by the absence of a clear demonstration of 
stereoscopic vision in mice. A number of studies of depth perception have been made on 
rats that test either their ability to jump across a gap or their performance on a visual cliff 
(Howard, 2002). Because these studies did not compare monocular with binocular 
performance or control for the use of motion cues such as motion parallax, the possible 
contribution of stereoscopic vision was unclear. Nonetheless, a recent study (Baroncelli, 
Braschi and Maffei, 2013) that tested rats on a graded series of depth differences between 
the two sides of a visual cliff apparatus provided evidence of superior performance with use 
of both eyes suggestive of the presence of stereopsis. However, the possible use of motion 
parallax could not be ruled out. Innovative new tests of the depth perception of rats and 
mice that target the specific use of retinal disparity cues are needed to establish whether they 
possess true stereoscopic vision.   
 
Table 6.1 lists the results of existing measurements of various visual thresholds, the methods 
of assessment as well as the presence or absence of particular key anatomical and 
physiological features in the central visual pathways for the various common animal models 
for amblyopia. As with clinical screening for amblyopia in humans and to assess progress 
during and following treatment, assessment of visual performance in animal models is most 
commonly made in terms of the effects on visual acuity. The depth of amblyopia in humans 
is graded according to the specific acuity measure employed with the severity of the deficit 
increasing from grating acuity to letter acuity to the various hyperacuities such as vernier 
acuity. Grating acuity has been measured in all the commonly employed species including 
mice and spans a range of six octaves from 0.5 cycles per degree in mice (Prusky and 
Douglas, 2003) to 30 cycles per degree in macaques, or 100-fold with respect to humans. 
The vast discrepancies of grating acuity across species reflect fundamental differences in 
retinal anatomy that include the lack of a fovea in species other than primates, or variation in 
the extent of central retinal specialization with respect to cone density. Vernier acuity, which 
is likely a more accurate reflection of behavioral amblyopic deficits, has not yet been 
measured in mice, but has been measured in rats (Seymoure and Juraska, 1997). 
Table 6. 1. 
  
The perceptual performance space for the different species that are commonly employed as 
animal models of amblyopia and the assessment methods employed.  Also shown are the 
presence or absence of various anatomical and physiological features in the central visual 
pathways. 
 
Anatomical and physiological features 
 Macaque Marmoset Cat Rat Mouse 
Ocular 
dominance 
columns 
+ ± + - - 
Visual 
processing 
streams 
+ + + ? + 
[1] 
Disparity 
selectivity 
+ + + ? + 
[2] 
Physiological 
and anatomical 
MD effects 
Severe 
shrinkage of 
OD 
columns, 
drastic OD 
shift 
Appearance 
of deprived-
eye columns, 
drastic OD 
shift 
[3] 
Severe 
shrinkage of 
OD 
columns, 
drastic OD 
shift 
Moderate 
OD shift 
Moderate 
OD shift 
(reduction in 
OD index 
by ~0.3) 
Cortical 
Suppression 
+ 
[4, 5] 
? + 
[6, 7] 
+ 
[8] 
? 
 
 
Perceptual performance space 
 Macaque Marmoset Cat Rat Mouse 
Stereopsis ++ + + +? 
[9] 
? 
First-order 
(grating) acuity 
30 c/deg >10 c/deg 6 c/deg 1 c/deg  
[10] 
0.5 c/deg 
[11] 
Second-order 
(Vernier) acuity 
10-12 sec arc 
[12] 
? 1.2 min arc 
[13] 
34 min  
[14] 
? 
Contrast 
sensitivity 
~100 at 5 
c/deg 
[15] 
? ~100 at 0.3 
c/deg 
[16] 
~30 at 0.05 
c/deg 
[17] 
C57BL/6 
mice 6%, 
[18] 
MD effects on 
visual function 
Fct 
blindness 
? Fct 
blindness 
1 octave 
reduction in 
acuity 
1 octave 
reduction in 
acuity 
 
 
Assessment methods 
 Macaque Marmoset Cat Rat Mouse 
Single- or 
multi-unit 
recording 
+ + + + + 
VEP / EEG 
recording * 
+ + + + + 
Intrinsic signal 
imaging 
+ + + + + 
Two-photon 
imaging 
(+) + + + ++ 
Neuro-
anatomical 
markers (IEG 
+ (+) + + + 
expression) 
Genetic 
modification 
- + 
[19] 
- + ++ 
Behavioural 
tests of acuity 
+ + + + + 
* Note that this is the only technique that is also widely used in humans 
References for specific data entered in Table 6.1 are as follows: 1. Wang et al., 2012; 2. Scholl et al., 2013; 3. 
Sengpiel et al., 1996 ; 4. Smith et al., 1997; 5. Sengpiel and Blakemore, 1996; 6. Chino et al., 1994; 7. Sengpiel et 
al., 1994; 8. Pietrasanta et al., 2014; 9. Baroncelli et al., 2013; 10. Prusky et al., 2000; 11. Prusky et al., 2003; 12. 
Kiorpes, 1992; 13. Murphy and Mitchell, 1999; 14.Seymoure and Juraska, 1997; 15. De Valois et al., 1974; 16. 
Bisti and Maffei, 1974; 17. Birch and Jacobs, 1979; 18. Yeritsyan et al., 2012; 19. Sasaki et al., 2009. 
 
 
Not only is acuity substantially lower in typically reared rodents compared to primates, but 
the reduction in acuity upon monocular deprivation is dramatically different across species. 
While rodent models exhibit a single octave reduction in grating acuity, macaques remain 
effectively blind in the deprived eye after this manipulation (Harwerth, Smith, Boltz et al., 
1983). Kittens also appear blind immediately after MD but show some recovery afterward 
(Giffin and Mitchell, 1978; Mitchell, 1988). Participants discussed but without reaching 
consensus, whether the discordant magnitude of the effects of MD reflected fundamental 
anatomical or physiological dissimilarities in the organization of visual pathways across 
species, or else arose from species differences in the plasticity of neural circuitry.  
 
In connection with the discussion of the effects of MD some participants questioned 
whether this manipulation was the most appropriate way to model deprivation amblyopia as 
a way to mimic the development of cataracts. And, as debated in other Targeted Sessions, 
amblyopia is at its root a binocular condition so that the ability to probe the status of 
binocular vision across different species including tests of stereopsis and suppression is 
important. While mice exhibit neural correlates of disparity selectivity in visual cortex 
(Scholl, Burge and Priebe, 2013), it is not known whether they possess stereopsis and if so 
whether it is affected by experiential manipulations such as MD.   
 
 
Recommendation 2.   Comparative Measurements of Key Perceptual Abilities Across 
Species by Use of the Same or Very Similar Techniques    
    
     
While the expansion of technologies in physiology, imaging, and molecular biology has  
allowed neural circuits to be probed at unprecedented resolution, many of these techniques 
are not equally applicable across species and especially not to humans. Mice in particular 
offer high throughput molecular characterization of visual circuits and changes to them 
during development and in response to experiential manipulation. On the other hand, NHP 
such as macaques easily outperform rodents on visual tasks that accurately reflect human 
amblyopic deficits. Comparison of the perceptual abilities on various visual tasks has been 
made difficult by differences in the techniques employed across species. Rather than an 
exclusive focus on identification of the techniques best suited for each individual species, 
participants thought it would be valuable to propose a common technique that could be 
deployed with ease across species including humans. Discussion focused quickly upon the 
use of electrophysiological measures and particularly the use of various types of visual 
evoked potentials (VEP) and, in particular, upon the steady-state VEP, or the SSVEP 
(Norcia, Applebaum, Ales et al., 2015). A VEP corresponds to electrical changes in large 
populations of neurons in the cortex, and can be recorded from the surface of the brain 
non-invasively using electroencephalography (EEG). High-density EEG recordings can be 
used to improve source localization of this common technique and are applicable across 
species, including humans. By use of a fan of electrode contacts placed strategically over the 
scalp it is possible to obtain a high yield analysis of visual responses across different visual 
areas. A particular form of SSVEP, the sweep VEP that measures the changes in response to 
a stimulus that is swept (varied) over a range of values is used widely to measure various 
visual thresholds. For assessment of acuity or contrast sensitivity the SSVEP is measured in 
response to parametric sweeps of gratings of different spatial frequency or contrast. The 
method is fast and has been used on human infants and on various species including NHP 
(Nakayama & Mackeben, 1982) and rodents under light anesthesia (Guire, Lickey and 
Gordon, 1999; Xu, Tian, Zhang et al., 2015). 
 
On the basis of this discussion, participants proposed that use of the SSVEP would be the 
most efficient way to assess visual thresholds across species and in the various animal 
models of amblyopia. In addition to measurement of key visual thresholds across species by 
use of the SSVEP, the suggestion was made that certain methods of non-invasive imaging 
could also be used to assess the functional integrity of the visual cortex and possibly other 
visual areas in the various animal models of amblyopia. 
 
Recommendation 3. Advocacy for the Use of Marmosets as an Animal Model of 
Amblyopia 
 
 
Despite the value of rodents and carnivores such as cats as animal models of amblyopia, 
there are issues for which there is arguably no alternative to the use of NHPs. In addition to 
the need for their use to refine the optimum timing and the dosage for projected 
interventions in human patients with amblyopia, as a species with a highly developed fovea, 
NHP may provide the only valid choice to model strabismic amblyopia. The presence of a 
similar organization of higher visual cortical areas to that observed in humans and which are 
likewise specialized for processing complex visual stimuli, attracts use of non-human 
primates for study of the underlying neural basis for the deficits of various higher visual 
functions observed in amblyopia. Macaque monkeys are easily trained to make very 
repeatable behavioral observations and the documented perceptual deficits associated with 
early amblyogenic manipulations are remarkably similar to those demonstrated by human 
patients with amblyopia. 
 
In addition to the case that can be made for the use of NHP to model human amblyopia, it 
is very important to recognize their participation in translation of the results from animal 
studies to clinical trials. These issues are raised in the discussion of Recommendation 4 that 
follows. 
 
Most of the earliest studies of the functional anatomy and physiology of the visual cortex 
and its development, including investigations of the consequences of early periods of 
selected visual deprivation for anatomy, physiology and behavior, were conducted on 
macaque monkeys. As such, there exists a large body of data documenting the close 
similarity of spatial vision, oculomotor characteristics as well as organization of higher visual 
cortical areas between macaques and humans, which makes the choice of the former the 
ideal primate animal model. Unfortunately, there are considerable practical barriers to their 
use. Macaques are expensive to purchase and to house. There are regulatory barriers as well 
as vociferous resistance to their use from the public and media expressing growing ethical 
concerns. Many of these issues are exacerbated upon consideration of their use as animal 
models of amblyopia where experimental manipulations must be made in infancy. The long 
gestation (5.5 months), the unitary litter size, the length of critical period of vulnerability to 
monocular deprivation (> 1 yr) together with the need for experimental interventions near 
birth, in most cases requires the existence of an on-site breeding colony. The recent closure 
of the New England Primate Center and the continual pressures from diverse sources 
directed against remaining macaque colonies (in North America as well as in Europe) 
indicate that the ability to initiate a new macaque breeding colony would be close to 
impossible. As many of the same barriers to use of macaque monkeys apply to familiar New 
World monkey species, participants at the Targeted Session Group discussed the potential 
use of marmosets as a primate model of amblyopia. This discussion benefited from the 
insight provided by Dr. Sam Solomon (University College, London) who has conducted a 
number of investigations of the central visual pathways of marmosets in recent years in 
collaboration with Dr. Marcello Rosa and others at Monash University (Melbourne, 
Australia).  
 
Detailed information relevant to the breeding and housing of marmosets is provided in a 
multi-center review (Tardiff, Smucny, Abbott et al., 2003). The arguments for their use in 
visual neuroscience (Solomon and Rosa, 2014; Mitchell and Leopold, 2015) and in particular 
as a model for amblyopia are worth serious consideration.  Marmosets possess a fovea with a 
peak cone density of 200,000 cones/mm2 similar to that observed in macaque monkeys and 
humans. While the volume of the marmoset brain is approximately 12 times smaller than 
that of macaques, the cerebral cortex is relatively smooth so that the vast majority of the 
visual cortex lies exposed and not buried in sulci. Importantly, V2 as well as the third tier 
visual also lie exposed on the cerebral surface. Important as these features of the marmoset 
cortex are for investigations of the neural basis for vision, they are more than matched by 
the short gestation time, large litter size and the comparative ease of housing. The fact that 
they can be housed socially in groups of 5 or 6 reduces the costs of colonization. In a multi-
colony database of 3,714 marmosets, the litter size ranged from 1-4, with twins as the most 
common but more than a third were triplets or quadruplets (see Table 2 from Tardiff, 
Smucny, Abbott et al., 2003). The gestation time of 143 days is shorter than that for 
macaques (164 days) but longer than that for cats (63 days). Although data as yet are 
somewhat conflicting, ocular dominance columns in V1 of marmosets, like other New 
World monkeys, may be transitory or even variable across animals (Roe, Fritsches and 
Pettigrew, 2005) but have been shown to exhibit experience-dependent change in response 
to MD (Sengpiel, Troilo, Kind et al., 1996; Fonta, Chappert and Imbert, 2000) or enucleation 
(Ribic, Flugg, Schlumbohm et al., 2011).  
 
A major additional argument for the use of marmosets beyond the development of a new 
non-human primate model for amblyopia is the potential for genetic modification (Sasaki, 
Suemizu, Shimada et al., 2009). As summarized in a recent Nature News item, our 
Recommendation is reinforced by the launch of a Brain/MINDS project in Japan to study 
cognition and cognitive disorders in marmoset models (Cyranoski, 2014). Higher visual 
functions including contrast sensitivity or vernier acuity have not yet been experimentally 
investigated in the marmoset, but a physiological substrate for stereopsis has been 
documented (Table 6.1). Our recommendation for the increased use of marmosets as a NHP 
model for amblyopia should not be taken to mean that they replace completely the well-
established macaque model as the latter holds a number of advantages over marmosets for 
application of particular techniques. For example, the larger body size of macaques allows 
for both much longer daily behavioral measurements as well as longer awake behavioral 
recording experiments. Moreover, their longevity makes them invaluable for extended 
behavioral studies that also serve in part to mitigate against their high initial cost. 
 
Recommendation 4.  A Balanced Suggestion for Replication of a Laboratory Finding 
Made on One Animal Model to a “Higher“ Species as a Necessary Step to a Clinical 
Trial: a “Two-Species Rule” 
 
 
For the most part, the use of animal models in the study of amblyopia should have a clear 
goal of applying the findings of such studies eventually to clinical practice. In some cases, 
this would mean the development of a therapy, either behavioral or pharmacological, that 
could be tested in clinical trials. It is therefore prudent to understand how to most efficiently 
and safely transition between the world of animal models and human patients.  
 
No species matches the efficiency (both cost and time) or the genetic toolbox available to 
probe the visual system for new approaches to treatments as the mouse. Unfortunately, the 
relative simplicity of their visual system is the least comparable to humans, although recent 
studies have found underappreciated complexities in the mouse visual pathway (e.g., Scholl, 
Burge and Priebe, 2013) as well as sophisticated perceptual abilities such as the perception of 
motion coherence (Douglas, Neve, Quittenbaum et al., 2006). They also exhibit qualitative 
differences in visual plasticity compared to other models such as cats and primates. For 
example, mice living in environmentally enriched conditions display ocular dominance 
plasticity well beyond the classical critical period (Greifzu, Pielecka-Fortuna, Kalogeraki et al., 
2014), a finding not replicated in other mammals. Mice also exhibit a form of plasticity in 
adulthood that is not observed in cats or NHP (Satwell, Frenkel, Philpot et al., 2003). In 
addition, strategies shown to be successful in one species may be less so in another. For 
example, reverse occlusion but not binocular visual exposure is quite effective in promoting 
recovery when combined with various approaches to enhance plasticity in rats (He, Ray, 
Dennis et al., 2007), while cats benefit from binocular visual experience (Mitchell, Cynader 
and Movshon, 1977; Mitchell, 1988; Mitchell, Gingras and Kind 2001). Dark exposure is 
effective in promoting recovery from long-term monocular deprivation in adult rats (He, 
Ray, Dennis et al., 2007), but is only effective in juvenile cats (Duffy and Mitchell, 2013; 
Holman, Duffy and Mitchell, 2014; Duffy, Lingley, Holman et al., 2016). Varied responses 
across species are also observed in response to pharmacological treatments. For example, 
enzymatic digestion of perineuronal nets with chondroitinase restores ocular dominance 
plasticity in adult rats (Pizzorusso, Medini, Landi et al., 2006) but has much less of a 
beneficial effect in cats (Vorobyov, Kwok, Fawcett et al., 2013); Fluoxetine promoted 
recovery from MD in rats (Maya-Vetencourt, Sale, Viegi et al., 2008) but according to a Press 
Release (http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=453937) 
failed to show an enhancement of results above that achieved by video training in a recent 
Phase II  human clinical trial.               
 
As researchers we are torn between two extreme viewpoints with respect to the steps to a 
clinical trial. At one extreme is the view that a result from a single species provides sufficient 
evidence to mount a Proof of Principle clinical trial. Of course, there are variations of this 
viewpoint depending on the specific species employed; results obtained from NHP would 
likely meet with wider acceptance than data from other species. The opposing and more 
conservative viewpoint is that it is necessary for confirmation of the initial result in at least 
one other species, with a NHP serving as the second species in the extreme interpretation of 
such a “two-species” rule.  
   
The strongest argument for the acceptance of results from a single species as sufficient to 
mount a clinical trial is to accelerate the time between laboratory discovery and a clinical trial. 
However, such hasty action may jeopardize the clinical trial because of failure to optimize 
the treatment parameters, the patient population or the timing of the intervention. Because a 
negative finding on a clinical trial subtracts from the ability to conduct trials in the future, it 
is important that the urge to “fast-track” a laboratory finding to the clinic be tempered by a 
careful evaluation of the various parameters of the intervention. Failure to optimize the 
treatment parameters such as dosage on a clinical trial has the potential to jeopardize 
conduct of future trials of a different and potentially very effective dosage of the same 
treatment. Moreover, a negative clinical trial based on results from a single species also 
diminishes the ability in the future to argue for the relevance of that particular species as a 
viable model of amblyopia. It is also important to recognize that failure of a clinical trial 
provides ammunition for activist groups opposed to the use of all animal models. As it was 
perceived that treatment parameters on a clinical trial based upon results obtained from 
species other than NHP’s would need to be tweaked by data obtained from a second species, 
participants vacillated between various versions of the alternative viewpoint.  
 
The viewpoint that discoveries from rodent or cat animal models be replicated first on 
NHP’s prior to a clinical trial inevitably introduces delay and reduces the number of possible 
treatments that could be explored. The suggestion of a two species “rule” with the caveat 
that two rodent species would probably not qualify, was considered a useful practical 
compromise as it increased substantially the ability to test numerous treatments. Upon 
progression to a cat model of a potential treatment based on findings in a rodent, a negative 
finding would make it unnecessary to proceed to tests on a NHP. An understanding of the 
efficacy and timing of manipulations in at least two species can elucidate how likely these 
treatments are to translate to humans. This consideration is made pointedly in consideration 
of pharmacological interventions in children. Because of the risk of off-target effects of 
pharmacological treatments, especially when prescribed to children with other brain regions 
likely undergoing sequential critical periods, special care should be taken to understand the 
efficacy of these drugs across species prior to clinical trials, not only for safety, but also to 
ensure translation of the optimum timing and dosage from animal models to humans. An 
example of a “two-species” examination of the use of binocular retinal silencing with intra-
vitreal injection of tetrodotoxin (TTX) as a replacement for darkness to treat the 
consequences of a prior early period of monocular deprivation has recently been published 
(Fong, Mitchell, Duffy et al., 2016). The study was conducted in three different laboratories 
on two species (mouse and cat) and reported very similar outcomes and thus replication of 
the results in both species.  
 
 
Fuelling the debate on this Recommendation were considerations of two main issues that 
related to the problem of translation of dosage and timing of interventions from animals to 
humans. The difficulty of testing dosage of treatments was emphasized by the recent report 
of the somewhat ambivalent preliminary findings of a clinical trial on the use of a re-
purposed drug, the SSRI Citalopram, that was reported at the March 2016 meeting by Ben 
Thompson. The ability to employ a FDA-approved drug has many benefits, not the least 
being the ability to fast-track a clinical trial. On the other hand, because the prior approved 
use of the drug was for administration to adults, the dosage applied to children or young 
adults in the amblyopia trial was deliberately conservative. This raised the issue of how to 
interpret the results of the trial, since it is possible that the drug was ineffective at the dosage 
applied. It also pointed to the many difficulties associated with the establishment of dosage 
levels. With respect to translation of dosage levels from adults to children guidance may be 
sought from the calculations made for the effective dosage levels of drugs, such as cancer 
drugs, that are commonly used on humans from children to adults where multiple 
considerations including weight, allometric and metabolic measures are applied.  
 
A related concern is the issue of how to translate developmental and susceptibility timelines 
across species to humans so that the timing of treatment would be optimal. During this 
discussion it was pointed out that, for example, the common 4:1 multiple applied to translate 
developmental timelines from macaques to humans applies only to resolution acuity and 
does not apply to relative eye growth where the ratio is 3:1. Development of an equivalent 
ratio between species for stereoacuity is hampered by the existence of too many isolated 
studies of monkeys on small numbers and the use of very different stereo measures. For 
example, only a single study exists (O’Dell and Boothe, 1997) of the time of emergence of 
stereopsis in macaques. Extrapolation of the developmental timeline of the cat to humans is 
complicated by the delay in eye opening as well as the slow disappearance of the hyaloid 
artery around the crystalline lens in cats.  
 
Conclusions 
In contrast to the comparative sparsity of animal models of many other neurological clinical 
disorders, study of the basis of amblyopia and pursuit of new avenues for its treatment are 
guided by a rich variety of animal models that employ a common set of experiential 
manipulations on divergent species. Our Recommendations for the application of Animal 
Models focused on the use of a monocular deprivation as the most common experiential 
manipulation, that has been employed widely with graded success across species from 
rodents to NHPs. The use of a common manipulation has aided comparison of the results 
across species but also permitted identification of gaps in our knowledge of the perceptual 
abilities of certain species including rodents and marmosets.  
 
 Two of our Recommendations (1 & 2) suggest particular gaps in knowledge that 
need to be filled and also common methods of assessment that could be applied 
across species as an aid to comparison of perceptual performance. Sometimes 
assumptions are made about the perceptual abilities of a particular species without 
hard evidence. A case in point is the assumption that rodents do not possess 
stereopsis in the face of a lack of tangible evidence of their ability to employ 
stereoscopic vision. Tangible data on this issue would assist discussion of the role of 
binocular neurons in the rodent visual cortex. On the basis of the demonstration of 
large independent eye movements in freely moving rats, it has been suggested 
(Wallace, Greenberg, Sawinski et al., 2013) that the main purpose of binocular 
neurons may be to ensure a large panoramic visual field above them to escape 
predation from raptors. 
 
 Our third Recommendation for increased use of marmosets as a NHP species was 
suggested as a means to speed the path to clinical trials in situations where 
information from NHPs was deemed essential. 
 
 Our final Recommendation could be deemed a principle or strategy to guide the path 
from results obtained from an animal model to a clinical trial. For translation to a 
clinical trial, participants advocated the principle of a “two-species replication” with 
the suggestion that the two species not both be rodents. Participants thought that a 
wider adoption of marmosets as models of amblyopia may lead eventually to the 
principle that one of the two species be a NHP.  
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